Skip to main content

Table 2 Health-Related Quality of Life at 1 year follow-up in oesophageal and GOJ cancer in patients

From: Health-related quality of life one year after the diagnosis of oesophageal cancer: a population-based study from the Swedish National Registry for Oesophageal and Gastric Cancer

 

All*

n = 1156

Reference population

n = 4910

Curative treatment

n = 884

Palliative

treatment

n = 267

QLQ-C30

Mean (CI)

Mean (CI)

Mean (CI)

Mean (CI)

 Global health/QOL

60 (58 to 62)

76 (76 to 77)

61 (60 to 63)

55 (51 to 58)

Functions

 Physical function

73 (72 to 75)

88 (87 to 89)

76 (75 to 78)

64 (61 to 68)

 Role function

64 (62 to 66)

88 (88 to 89)

66 (64 to 68)

56 (51 to 60)

 Emotional function

75 (74 to 76)

86 (85 to 86)

76 (75 to 78)

71 (67 to 74)

 Cognitive function

82 (80 to 83)

88 (88 to 89)

82 (81 to 84)

79 (76 to 82)

 Social function

71 (69 to 72)

91 (91 to 92)

72 (70 to 74)

65 (61 to 69)

Symptoms

 Fatigue

43 (41 to 44)

19 (18 to 20)

41 (39 to 42)

49 (46 to 53)

 Nausea and vomiting

17 (15 to 18)

3 (2 to 3)

16 (15 to 18)

18 (15 to 21)

 Pain

26 (25 to 28)

19 (18 to 20)

25 (23 to 27)

31 (27 to 35)

 Dyspnoea

36 (34 to 38)

16 (16 to 17)

35 (33 to 37)

41 (37 to 45)

 Insomnia

28 (26 to 30)

18 (17 to 18)

27 (25 to 29)

31 (27 to 35)

 Loss of appetite

30 (28 to 32)

3 (3 to 4)

28 (26 to 30)

38 (33 to 43)

 Constipation

14 (12 to 15)

5 (5 to 6)

11 (10 to 13)

22 (18 to 25)

 Diarrhoea

21 (19 to 22)

6 (5 to 6)

23 (21 to 25)

13 (10 to 16)

 Financial

14 (12 to 16)

4 (4 to 5)

14 (13 to 16)

13 (10 to 16)

QLQ-OG25

Function

 Body Image

72 (70 to 74)

 

74 (71 to 76)

67 (63 to 72)

Symptoms

 Dysphagia

24 (22 to 26)

 

22 (20 to 24)

32 (28 to 36)

 Eating

33 (32 to 35)

 

32 (30 to 34)

37 (33 to 41)

 Reflux

24 (22 to 25)

 

24 (23 to 26)

21 (18 to 25)

 Odynophagia

20 (18 to 21)

 

19 (17 to 20)

23 (20 to 27)

 Pain and discomfort

26 (25 to 28)

 

26 (24 to 28)

27 (23 to 31)

 Anxiety

46 (44 to 48)

 

44 (42 to 46)

52 (48 to 56)

 Eating with others

21 (19 to 22)

 

18 (16 to 20)

29 (25 to 34)

 Dry mouth

30 (28 to 32)

 

29 (26 to 31)

36 (32 to 40)

 Trouble with taste

24 (22 to 26)

 

22 (20 to 24)

31 (27 to 36)

 Trouble swallowing saliva

12 (11 to 14)

 

11 (10 to 13)

17 (13 to 20)

 Choked when swallowing

18 (16 to 19)

 

17 (15 to 19)

20 (16 to 23)

 Trouble with coughing

31 (29 to 32)

 

30 (28 to 32)

31 (27 to 35)

 Trouble talking

12 (10 to 13)

 

11 (10 to 13)

14 (11 to 17)

 Weight loss

31 (29 to 33)

 

30 (28 to 33)

33 (29 to 38)

Experience of Hair loss (fewer responders)

21 (18 to 24)

 

22 (18 to 25)

19 (13 to 25)

  1. * All patients answering questionnaire, including palliative, curative and five patients with unknown treatment intention
  2. Mean scores and 95% confidence intervals (CI) in patients who completed European Organisation for Research and Treatment of Cancer QLQ-C30 questionnaire and oesophageal module QLQ-OG25, describing all patients and stratified by curative and palliative treatment intent, and also including a Swedish reference population